Equities

Shanghai INT Medical Instruments Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Shanghai INT Medical Instruments Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (HKD)30.90
  • Today's Change-0.10 / -0.32%
  • Shares traded151.80k
  • 1 Year change+8.04%
  • Beta0.3364
Data delayed at least 15 minutes, as of Feb 06 2026 08:08 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Shanghai INT Medical Instruments Co Ltd, formerly Shanghai Kindly Medical Instruments Co Ltd, is a China-based company principally engaged in the research, development, production and sales of intracardiac interventional devices. The Company operates its businesses through two segments. The Intracardiac Interventional Business segment is mainly engaged in the sales, manufacturing and research and development of intracardiac interventional medical devices and related molds, standard parts and masks. The Other segment is engaged in the research and development of other interventional medical devices, such as neurointerventional medical devices and heart valve implantable medical devices. The Company mainly operates its businesses in the domestic market and overseas markets.

  • Revenue in HKD (TTM)1.04bn
  • Net income in HKD201.35m
  • Incorporated2006
  • Employees2.01k
  • Location
    Shanghai INT Medical Instruments Co LtdNo.925 Jinyuan One RoadJiading DistrictSHANGHAI ChinaCHN
  • Phone+86 2 159140056
  • Fax+86 2 169000013
  • Websitehttps://www.int-medical.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Peijia Medical Ltd751.41m-253.43m4.29bn1.04k--1.93--5.71-0.3831-0.38311.133.310.25611.4017.04717,676.40-8.76-26.57-10.02-28.9969.2571.23-34.21-247.651.49-15.300.1396--39.53101.1342.28--83.33--
Acotec Scientific Holdings Ltd667.22m113.56m4.41bn645.0037.782.7125.506.610.37250.37252.215.180.33531.063.531,026,488.005.710.24676.450.28975.2381.3317.020.71225.57--0.14060.0012.6933.72260.8817.7483.44--
MicroPort CardioFlow Medtech Corp413.63m5.46m5.03bn417.00337.480.77647.0112.160.00230.00230.17761.020.14231.001.77961,932.000.0886-13.380.0996-16.8469.0864.410.6228-124.496.50--0.112--7.5475.8589.51--26.60--
Modern Dental Group Ltd3.50bn478.00m5.48bn8.59k11.511.848.771.570.50930.50933.733.190.82979.044.89492,119.5011.428.0813.349.6054.0651.8513.7610.322.7654.800.199940.786.056.990.965120.360.4449--
Lepu Scientch Mdcl Tchnlgy Shnghi Co Ltd621.52m323.40m5.63bn374.0017.422.5415.849.070.93270.93271.796.400.24940.83236.061,979,362.0012.987.8314.899.2887.2389.1852.0335.625.03--0.000681.7844.4032.2862.2236.4582.59--
Yidu Tech Inc836.91m-100.10m5.86bn823.00--1.36--7.01-0.0948-0.09480.79124.100.159524.781.341,016,906.00-2.03-24.00-2.38-30.0834.4135.64-12.72-123.004.37--0.0321---11.415.0839.58--26.45--
BrainAurora Medical Technology Ltd191.86m-236.70m6.08bn174.00--21.82--31.68-0.1869-0.18690.15150.220.3274--1.241,206,656.00-40.54---112.29--41.26---123.83-----10.130.6324--82.01--44.78------
Shanghai INT Medical Instruments Co Ltd1.04bn201.35m6.55bn2.01k25.842.5821.296.321.201.206.1812.000.38022.0511.49597,230.507.988.4610.149.8160.9960.3421.0024.360.96626.740.225324.3113.1724.3615.6312.6817.46--
MicroPort NeuroScientific Corp828.84m229.12m6.64bn522.0029.033.4122.528.010.39690.39691.443.380.35431.293.101,572,757.009.696.0411.237.0173.5874.5827.3616.604.71142.060.014135.6914.4432.9074.6340.172.49--
China Isotope & Radiation Corp8.58bn477.34m6.74bn3.36k14.131.185.170.7861.491.4926.8217.870.51863.141.752,547,766.006.226.3112.9912.9948.2655.5411.9911.951.5168.900.27530.1614.1613.689.624.3311.8123.56
AK Medical Holdings Ltd1.56bn332.32m6.86bn1.00k20.552.2315.104.400.29690.29691.392.740.4111.062.661,632,118.008.778.0110.899.6959.2763.0121.3420.182.88--0.074722.5723.087.7650.420.51418.660.1873
LifeTech Scientific Corp1.49bn80.92m7.92bn1.27k91.861.8767.675.300.01860.01860.34390.91610.26150.69758.111,073,346.000.48166.080.58227.2672.6078.531.8420.722.09--0.13080.002.8814.28-15.5211.4715.11--
Zylox-Tonbridge Medical Technolgy Co Ltd1.01bn171.73m8.31bn875.0046.602.2338.978.220.52880.52883.1211.060.25731.40425.711,155,602.004.37-3.214.84-3.4471.4772.7516.98-21.205.16--0.0257--48.27175.65227.34--35.70--
Data as of Feb 06 2026. Currency figures normalised to Shanghai INT Medical Instruments Co Ltd's reporting currency: Hong Kong Dollar HKD

Institutional shareholders

29.83%Per cent of shares held by top holders
HolderShares% Held
China Orient Asset Management Co. Ltd. (Investment Management)as of 26 Jan 202618.84m18.08%
OrbiMed Advisors LLCas of 04 Jun 20259.00m8.64%
UBS Asset Management (Hong Kong) Ltd.as of 31 Oct 20252.77m2.65%
Dimensional Fund Advisors LPas of 08 Jan 2026455.20k0.44%
Dimensional Fund Advisors Ltd.as of 30 Nov 202515.83k0.02%
DFA Australia Ltd.as of 30 Nov 20255.03k0.01%
More ▼
Data from 30 Sep 2025 - 26 Jan 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.